BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.250
+0.010 (0.81%)
At close: Feb 6, 2026, 4:00 PM EST
1.291
+0.041 (3.29%)
After-hours: Feb 6, 2026, 7:52 PM EST
BioCardia Market Cap
BioCardia has a market cap or net worth of $13.27 million as of February 6, 2026. Its market cap has increased by 37.80% in one year.
Market Cap
13.27M
Enterprise Value
8.19M
1-Year Change
37.80%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $13.27M, a decrease of -54.37%. That is a compound annual growth rate of -8.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 13.16M | -0.80% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 13.74M |
| BioLineRx | 13.49M |
| GT Biopharma | 13.23M |
| OSR Holdings | 13.20M |
| Allarity Therapeutics | 13.03M |
| Cadrenal Therapeutics | 12.53M |
| CytoMed Therapeutics | 12.46M |
| Kairos Pharma | 12.28M |